In addition to the TGA approval, users in the U.K. will be able to purchase the Lightning®-enabled Dario device at the end of this month while sales of the device will begin in Australia by January 2018. DarioHealth is still waiting on approval from regulatory agencies in the U.S. and Canada, which is expected in the coming months. About DarioHealth Corp. DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down.